Acute lung injury during antithymocyte globulin therapy for aplastic anemia.

The case of a 33-year-old man with aplastic anemia who experienced recurrent episodes of hypoxemia and pulmonary infiltrates during infusions of antithymocyte globulin (ATG) is described. With the use of high-dose corticosteroids, the patient's original episodes resolved, and were subsequently prevented before additional administrations of ATG. Rare reports of an association between ATG and acute lung injury are found in the literature, but this is the first report of successful steroid-supported re-exposure. Although the mechanism of ATG-related acute lung injury remains uncertain, it may be parallel to the mechanism of transfusion-related acute lung injury because the pathogenesis of the latter relies, in part, on antileukocyte antibodies. ATG-related toxicity should be included in the differential diagnosis of new, infusion-associated pulmonary infiltrates, and corticosteroids may be a useful therapeutic consideration in the management.

[1]  P. Toy,et al.  TRALI--definition, mechanisms, incidence and clinical relevance. , 2007, Best practice & research. Clinical anaesthesiology.

[2]  C. Silliman,et al.  Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. , 2007, Blood.

[3]  A. Shorr,et al.  Acute respiratory distress syndrome after kidney transplantation: Epidemiology, risk factors, and outcomes , 2003, Critical care medicine.

[4]  P. Holland,et al.  TRALI: correlation of antigen‐antibody and monocyte activation in donor‐recipient pairs , 2003, Transfusion.

[5]  P. Bruzzi,et al.  Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). , 2001, Blood.

[6]  L. Ben-Noun.  Drug-Induced Respiratory Disorders , 2000, Drug safety.

[7]  C. Silliman,et al.  Transfusion-related acute lung injury. , 2005, Blood.

[8]  T. Martin,et al.  Lung cytokines and ARDS: Roger S. Mitchell Lecture. , 1999, Chest.

[9]  P. Foucher,et al.  Transient Pulmonary Infiltrates during Treatment with Anti-Thymocyte Globulin , 1999, Respiration.

[10]  G. D. Walton,et al.  Antithymocyte globulin-induced adult respiratory distress syndrome. , 1998, Archives of internal medicine.

[11]  P. Camus.  Respiratory disease induced by drugs. , 1997, The European respiratory journal.

[12]  S. Nussey,et al.  Rapid progression of fibrosing alveolitis and thyrotoxicosis after antithymocyte globulin therapy for aplastic anemia , 1995, Annals of Hematology.

[13]  Costanzo-Nordin Mr.  Cardiopulmonary effects of OKT3: determinants of hypotension, pulmonary edema, and cardiac dysfunction. , 1993 .

[14]  J. Williams,et al.  Postpartum immunologic-mediated pulmonary edema associated with transfusion of blood containing an anti-B-lymphocyte antibody. , 1989, The Western journal of medicine.

[15]  D. Murdock,et al.  ARDS following equine ATG therapy. , 1987, Chest.

[16]  N. Dean,et al.  Adult respiratory distress syndrome related to antilymphocyte globulin therapy. , 1987, Chest.

[17]  A. Nienhuis,et al.  Antithymocyte globulin reacts with many normal human cell types. , 1983, Blood.

[18]  Cosimi Ab.  The clinical value of antilymphocyte antibodies. , 1981 .

[19]  M. Costanzo-Nordin,et al.  Cardiopulmonary effects of OKT3: determinants of hypotension, pulmonary edema, and cardiac dysfunction. , 1993, Transplantation proceedings.

[20]  A. Cosimi.  The clinical value of antilymphocyte antibodies. , 1981, Transplantation proceedings.

[21]  G. Böhm,et al.  [Diffuse immunological lung damage due to heterologous anti-thymocyte serum]. , 1975, Langenbecks Archiv fur Chirurgie.